As of 2024-12-12, the EV/EBITDA ratio of Surface Oncology Inc (SURF) is -0.62. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. SURF's latest enterprise value is 50.24 mil USD. SURF's TTM EBITDA according to its financial statements is -80.52 mil USD. Dividing these 2 quantities gives us the above SURF EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.3x - 13.7x | 11.8x |
| Forward P/E multiples | 7.5x - 13.7x | 10.4x |
| Fair Price | (12.12) - (17.92) | (14.45) |
| Upside | -1232.7% - -1774.6% | -1450.4% |
| Date | EV/EBITDA |